Image | Product Name | API Name | Last Drug Patent Expires | Details | Year of start producing |
---|---|---|---|---|---|
CAS No.170908-81-3, DOTA-NHS ester | Lutetium (177Lu) vipivotide tetraxetan | 10/17/2034 (Lutetium (177Lu) vipivotide tetraxetan) | View detail » | 2023 | |
CAS No. 571189-49-6, 5-(4-methylpiperazin-1-yl)pyridin-2-amine | Trilaciclib | 7/23/2039 (Trilaciclib) | View detail » | 2020 | |
Cas No. 1374635-90-1, Spiro[cyclohexane pentane-1,8′(9′H )-pyrazino[1′,2′:1,5]pyrrolo[2,3-d ]pyrimidin]-6′(7′H )one, 2′-chloro- (ACI) | Trilaciclib; Lerociclib | 7/23/2039 (Trilaciclib) | View detail » | 2022 | |
Cas No. 1374635-87-6, 1,1-Dimethylethyl N-[[1-[(5-brmo-2-chloro-4-pyrimidinyl)amino]cyclohexyl]methyl]carbamate | Trilaciclib; Lerociclib | 7/23/2039 (Trilaciclib) | View detail » | 2022 |